12021191 15896901 15453947 12721505 18373914 11796486 16703404 11994118 16223861 29543624 - Search Results

Year	Number of Results
2002	3
2003	1
2004	1
2005	2
2006	2
2008	1
2018	1
2022	0

1

Mutational analysis of the mouse somatostatin receptor type 5 gene promoter.

Woodmansee WW, Mouser RL, Gordon DF, Dowding JM, Wood WM, Ridgway EC. Woodmansee WW, et al. Endocrinology. 2002 Jun;143(6):2268-76. doi: 10.1210/endo.143.6.8824. Endocrinology. 2002. PMID: 12021191

2

Growth arrest of thyrotropic tumors by thyroid hormone is correlated with novel changes in Wnt-10A.

Kerr JM, Gordon DF, Woodmansee WW, Sarapura VD, Ridgway EC, Wood WM. Kerr JM, et al. Mol Cell Endocrinol. 2005 Jun 30;238(1-2):57-67. doi: 10.1016/j.mce.2005.03.004. Mol Cell Endocrinol. 2005. PMID: 15896901

3

Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancer.

Alhamarneh O, Murphy J, Atkin SL, England RJ. Alhamarneh O, et al. J Laryngol Otol. 2004 Aug;118(8):653-4. doi: 10.1258/0022215041917853. J Laryngol Otol. 2004. PMID: 15453947

4

Somatostatin and somatostatin receptor physiology.

Barnett P. Barnett P. Endocrine. 2003 Apr;20(3):255-64. doi: 10.1385/ENDO:20:3:255. Endocrine. 2003. PMID: 12721505 Review.

5

[Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones].

Iglesias P, Díez JJ. Iglesias P, et al. Med Clin (Barc). 2008 Mar 15;130(9):345-50. doi: 10.1157/13117351. Med Clin (Barc). 2008. PMID: 18373914 Review. Spanish.

6

Early gene expression changes preceding thyroid hormone-induced involution of a thyrotrope tumor.

Wood WM, Sarapura VD, Dowding JM, Woodmansee WW, Haakinson DJ, Gordon DF, Ridgway EC. Wood WM, et al. Endocrinology. 2002 Feb;143(2):347-59. doi: 10.1210/endo.143.2.8636. Endocrinology. 2002. PMID: 11796486

7

Pituitary tumors arising from glycoprotein hormone alpha-subunit-deficient mice contain transcription factors and receptors present in thyrotropes.

Sarapura VD, Wood WM, Woodmansee WW, Haakinson DJ, Dowding JM, Gordon DF, Ridgway EC. Sarapura VD, et al. Pituitary. 2006;9(1):11-8. doi: 10.1007/s11102-006-7865-8. Pituitary. 2006. PMID: 16703404

8

Somatostatins and their role in thyroid cancer.

England RJ, Atkin SL. England RJ, et al. Clin Otolaryngol Allied Sci. 2002 Apr;27(2):120-3. doi: 10.1046/j.1365-2273.2002.00543.x. Clin Otolaryngol Allied Sci. 2002. PMID: 11994118 Review.

9

The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormone.

Woodmansee WW, Kerr JM, Tucker EA, Mitchell JR, Haakinson DJ, Gordon DF, Ridgway EC, Wood WM. Woodmansee WW, et al. Endocrinology. 2006 Jan;147(1):272-82. doi: 10.1210/en.2005-1013. Epub 2005 Oct 13. Endocrinology. 2006. PMID: 16223861

10

Effect of thyroid-stimulating hormone in 68Ga-DOTATATE PET/CT of radioiodine-refractory thyroid carcinoma: a pilot study.

Almeida LS, Araújo MC, Zantut-Wittmann DE, Assumpção LV, Souza TF, Silva CM, Argenton JL, Santos AO, Mengatti J, Ramos CD, Etchebehere EC. Almeida LS, et al. Nucl Med Commun. 2018 May;39(5):441-450. doi: 10.1097/MNM.0000000000000823. Nucl Med Commun. 2018. PMID: 29543624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results